Immunotoxin with in vivo T cell suppressant activity and methods of use
    6.
    发明授权
    Immunotoxin with in vivo T cell suppressant activity and methods of use 失效
    具有体内T细胞抑制活性的免疫毒素和使用方法

    公开(公告)号:US07517527B2

    公开(公告)日:2009-04-14

    申请号:US09389565

    申请日:1999-09-03

    IPC分类号: A61K39/00 C07K16/00 C12P21/08

    摘要: Provided is a method of treating an autoimmune disease in an animal comprising administering to the animal an antibody-DT mutant immunotoxin which routes by the anti-CD3 pathway, or derivatives thereof, under conditions such that the autoimmune disease is treated. In a further embodiment, the invention provides a method of treating T cell leukemias or lymphomas in an animal comprising administering to the animal an antibody-DT mutant immunotoxin which routes by the anti-CD3 pathway, or derivatives thereof, under conditions such that the T cell leukemias or lymphomas are treated.

    摘要翻译: 本发明提供一种治疗动物自身免疫性疾病的方法,其特征在于,在对自身免疫性疾病进行治疗的条件下,对该动物施用抗CD3通路途径的抗体-DD突变型免疫毒素或其衍生物。 在另一个实施方案中,本发明提供了一种治疗动物中的T细胞白血病或淋巴瘤的方法,其包括对所述动物施用抗CD3通路途径的抗体-DD突变体免疫毒素或其衍生物, 治疗细胞白血病或淋巴瘤。